Provided by Tiger Trade Technology Pte. Ltd.

TherapeuticsMD

2.08
+0.01500.73%
Volume:15.63K
Turnover:32.46K
Market Cap:24.02M
PE:-110.68
High:2.09
Open:2.06
Low:2.06
Close:2.06
52wk High:2.95
52wk Low:0.9900
Shares:11.57M
Float Shares:9.49M
Volume Ratio:0.57
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0187
EPS(LYR):-0.0527
ROE:-1.08%
ROA:-2.88%
PB:0.89
PE(LYR):-39.34

Loading ...

TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 23

TherapeuticsMD Inc. Stock Slides 14.1%, Underperforms Market

Dow Jones
·
Jun 19

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 16

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jun 12

TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jun 11

TherapeuticsMD Inc. Stock Sheds 5.5%, Underperforms Market

Dow Jones
·
Jun 09

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 05

TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Jun 03

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 30

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 22

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 21

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 19

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 14

TherapeuticsMD Q1 EPS $0.01 Up From $(0.06) YoY, Sales $724.000K Up From $393.000K YoY

Benzinga Earnings
·
May 13

TherapeuticsMD reports Q1 EPS 1c vs. (6c) last year

TIPRANKS
·
May 13

TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives

TIPRANKS
·
May 13

TherapeuticsMD swings to FY26 Q1 profit of $103,000; revenue rises 84.2% to $724,000

Reuters
·
May 13

TherapeuticsMD Inc - Company Continues to Evaluate Strategic Alternatives Including Acquisition or Merger

THOMSON REUTERS
·
May 13

Press Release: TherapeuticsMD Announces First Quarter 2026 Financial Results

Dow Jones
·
May 13

TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
May 12